View source for 20240018163. NEW THIAZOLOPYRIMIDINONE DERIVATIVES simplified abstract (Hoffmann-La Roche Inc.)

=NEW THIAZOLOPYRIMIDINONE DERIVATIVES=


==Organization Name==

[[:Category:Hoffmann-La Roche Inc.|Hoffmann-La Roche Inc.]]


[[Category:Hoffmann-La Roche Inc.]]

==Inventor(s)==

[[:Category:Virginie Brom of Blotzheim (FR)|Virginie Brom of Blotzheim (FR)]][[Category:Virginie Brom of Blotzheim (FR)]]

[[:Category:Cosimo Dolente of Allschwil (CH)|Cosimo Dolente of Allschwil (CH)]][[Category:Cosimo Dolente of Allschwil (CH)]]

[[:Category:Delphine Gaufreteau of Kembs (FR)|Delphine Gaufreteau of Kembs (FR)]][[Category:Delphine Gaufreteau of Kembs (FR)]]

[[:Category:Nadine Grether of Moehlin (CH)|Nadine Grether of Moehlin (CH)]][[Category:Nadine Grether of Moehlin (CH)]]

[[:Category:Fionn Susannah O'hara of Basel (CH)|Fionn Susannah O'hara of Basel (CH)]][[Category:Fionn Susannah O'hara of Basel (CH)]]

[[:Category:Matilde Piras of Basel (CH)|Matilde Piras of Basel (CH)]][[Category:Matilde Piras of Basel (CH)]]

[[:Category:Hasane Ratni of Habsheim (FR)|Hasane Ratni of Habsheim (FR)]][[Category:Hasane Ratni of Habsheim (FR)]]

[[:Category:Michael Reutlinger of Freiburg (DE)|Michael Reutlinger of Freiburg (DE)]][[Category:Michael Reutlinger of Freiburg (DE)]]

[[:Category:Walter Vifian of Sissach (CH)|Walter Vifian of Sissach (CH)]][[Category:Walter Vifian of Sissach (CH)]]

[[:Category:Claudio Zambaldo of Basel (CH)|Claudio Zambaldo of Basel (CH)]][[Category:Claudio Zambaldo of Basel (CH)]]

==NEW THIAZOLOPYRIMIDINONE DERIVATIVES - A simplified explanation of the abstract==


This abstract first appeared for US patent application 20240018163 titled 'NEW THIAZOLOPYRIMIDINONE DERIVATIVES

==Simplified Explanation==

The abstract of the patent application states that a compound of formula (i) can be used as a medicament. 

* The compound of formula (i) has potential applications as a medicament.
* The patent application describes the compound and its use as a medicament.
* The compound is defined in the description and claims of the patent application.
* The abstract does not provide specific details about the compound or its properties.
* The abstract does not oversell the compound or its potential benefits.

Potential Applications:
* The compound of formula (i) can be used as a medicament.
* It may have therapeutic applications in treating specific diseases or conditions.

Problems Solved:
* The compound may address specific medical problems or conditions.
* The patent application does not provide specific details about the problems solved.

Benefits:
* The compound may offer therapeutic benefits in the field of medicine.
* It may provide a new treatment option for certain diseases or conditions.


==Original Abstract Submitted==

wherein r—rand a-aare as defined in the description and in the claims. the compound of formula (i) can be used as a medicament.



[[Category:C07D519/00]]